Who should I contact about S2658?

Modern Action routes the generated message to your senators when that is the relevant target for this bill, using your address to confirm constituent status.

What does Modern Action include in the message about S2658?

The draft includes the bill number, your position, the reasons you selected, any personal context you add, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes.

In Senate Committee·Last action 69 days ago

Drug makers would have to match FDA filings with patent filings

Q: How do I support or oppose S2658?

Choose support, opposition, or changes. Modern Action uses that stance, the bill context, and any reasons you choose to draft a message you can review, edit, and send.

Officially: Medication Affordability and Patent Integrity Act

Drug and biologic makers would have to tell the FDA and patent office the same key facts. If they hide or leave out required patent information, it could weaken their case in a patent lawsuit. The bill may affect when cheaper generic or biosimilar medicines can compete, but it does not lower prices by itself.

Use this page to support, oppose, or ask Congress to amend S2658. Modern Action explains Medication Affordability and Patent Integrity Act in plain English, helps identify the right senators or representative, and generates a bill-specific message you can review before sending.

Where it stands

Sitting in Health

No vote scheduled. Constituent contact is what moves bills out of committee.

What this bill actually does

Drug and biologic companies would have to certify key patent-related information to the FDA. They would have to say it matches what they gave the U.S. Patent and Trademark Office.
Those companies would have to send the patent office certain FDA information about the same patents. They would also have to send related FDA responses.
The sharing rule would cover only information the patent office says matters to patentability. That means information that could affect whether a patent should be granted or kept, such as test data, manufacturing controls, and prior art statements.

↓ Why your message matters here

This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.

Where your representatives stand

Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.

Where this bill is in the process

Legislative timeline

✓

Introduced

Introduced in Senate

—

●

Senate Committee

Under Senate committee consideration

Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (8/1/2025)

AUG 1

○

Senate Floor Vote

Voted on by Senate

—

○

Passed Senate

Approved by Senate

—

○

House Review

Sent to House for consideration

—

○

Passed Both Chambers

Approved by both House and Senate

—

○

Signed into Law

Signed by the President

—

For more detail

Read deeper

Questions people ask about contacting Congress on S2658

How do I support or oppose S2658, Medication Affordability and Patent Integrity Act?

Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can review, edit, and send.

Who does Modern Action contact about this bill?

Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the generated message to your senators when that is the most relevant target for this bill.

What does Modern Action include in the message?

The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you review it before it sends.

Take action on S2658: Medication Affordability and Patent Integrity Act

This page is for understanding Medication Affordability and Patent Integrity Act, choosing whether you support it, oppose it, or want changes, and reviewing a generated message before it goes to Congress.

Modern Action keeps the action tied to the bill itself: what it would do, where it is in the process (committee), which office can still act, and what ask belongs in the message.

You are not starting from a blank form. Modern Action drafts the message around S2658, your stance, and the reasons you choose, then leaves the final review and edits to you.

Menu